Last updated: Nov 20, 2026, 12:00 AM

Kalaris Therapeutics, Inc. Exchange (NASDAQ, USD)

KLRS

1.28
-0.03 (-2.05%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-73.81%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
34.04M
Price/Sales
-
Ent value
32.74M
Price/Book
0.59
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.59%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.46
Daily high1.55
Daily low1.33
Daily Volume253K
All-time high10.98
1y analyst estimate17.67
Beta-
EPS (TTM)-1.86
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Kalaris Therapeutics, Inc.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
KLRSS&P500
Current price drop from All-time high-88.34%-11.46%
Highest price drop-86.98%-56.47%
Date of highest drop17 Nov 20269 Mar 2009
Avg drop from high-43.84%-10.64%
Avg time to new high24 days12 days
Max time to new high189 days1805 days